Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by lonc17on Mar 06, 2024 6:54pm
105 Views
Post# 35919317

RE:Time to get back to reality.

RE:Time to get back to reality.Canadafan, 

I already apologized for using the word "announced" and I corrected my statement by saying "he let everyone know."

But I see now that this statement might also be misinterpreted and I have already attempted to clarify my postion in my most recent post. 

The following is a fact and is in no way at all libelous. It also represents the full accounting and final position on my views of this event.

1. At this time it is unknown whether MC exercised or let the options expire. 

2. MC may be deliquent in his reporting this matter to SEDI, or it may be due to an exceptionally long blackout period by the company. 

3. If we discover that MC let his options expire then it is reasonable to infer that he believed ONC was worth less than $1.45 (the exercise price) on or about December 13, 2024.


<< Previous
Bullboard Posts
Next >>